Moheimani, Fatemeh - University of Newcastle - School of Biomedical Sciences and Pharmacy

个人简介

Fatemeh graduated from Faculty of Pharmacy, Shiraz, Iran with the Doctorate degree in Pharmacy (Pharm-D). She then moved to Australia to pursue her research career. Fatemeh completed her Master of Medical Science (by research: the effect of a novel polyunsaturated fatty acid on development of atherosclerosis in apoE deficient mice) at University of Adelaide in 2005 and her PhD (molecular mechanisms linking diabetes with atherosclerosis) at University of Sydney in 2009. She was offered various scholarships, travel grants and postgraduate grants, e.g. GlaxoSmithKline postgraduate grant (2007-2008: $25,000) during her postgraduate trainings. She also worked as a researcher and taught in various Medical Institutes and Universities. Fatemeh was offered her postdoctoral research fellow at RMIT University in 2010 where she was investigating molecular mechanisms that regulate platelet thrombus formation. During her position at RMIT, Fatemeh co-supervised several Masters and PhD students, acted as postdoctoral representative in school of medical sciences, was successful in obtaining several travel grants and attended prestigious national and international conferences such as Australian Vascular Biology Society (AVBS) meeting (2012), the Gordon Research Conference-Haemostasis, New Hampshire, USA (2012) and the International Society on Thrombosis and Haemostasis, Kyoto, Japan (2011). Fatemeh was then offered her postdoctoral fellow position in Respiratory Cell and Molecular Biology area at School of Biomedical Sciences and Pharmacy, University of Newcastle, in 2013, under the supervision of Prof Knight. She has established Prof Knight’s laboratory and collaborated closely with expertise in the field, including Prof Peter Wark and Prof Philip Hansbro to investigate the importance of tissue and cell specific mechanisms that contribute to the respiratory diseases, particularly asthma. Fatemeh is addressing how the structure and function of epithelial cells contribute to asthma.

研究领域

Fatemeh is a research scientist with background in Biochemistry/Pharmacy and extensive medical research experience in cardiovascular field. The outcomes of her research have revealed essential molecular mechanisms linking diabetes with atherosclerosis. Fatemeh has expanded her research expertise to the respiratory field since 2013. She is particularly interested in asthma and investigating the importance of tissue and cell specific mechanisms that contribute to the disease. Fatemeh is addressing how the structure and function of epithelial cells contribute to asthma.

近期论文

查看导师新发文章（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

2016 Hsu AC, Parsons K, Moheimani F, Knight DA, Hansbro PM, Fujita T, Wark PA, 'Impaired Antiviral Stress Granule and IFN-Ã Enhanceosome Formation Enhances Susceptibility to Influenza Infection in Chronic Obstructive Pulmonary Disease Epithelium.', Am J Respir Cell Mol Biol, 55 117-127 (2016) 2015 Hirota JA, Marchant DJ, Singhera GK, Moheimani F, Dorscheid DR, Carlsten C, et al., 'Urban particulate matter increases human airway epithelial cell IL-1 beta secretion following scratch wounding and H1N1 influenza A exposure in vitro', EXPERIMENTAL LUNG RESEARCH, 41 353-362 (2015) [C1] 2015 Sercombe L, Veerati T, Moheimani F, Wu SY, Sood AK, Hua S, 'Advances and challenges of liposome assisted drug delivery', Frontiers in Pharmacology, 6 (2015) [C1] 2015 Moheimani F, Roth HM, Cross J, Reid AT, Shaheen F, Warner SM, et al., 'Disruption of Ã-catenin/CBP signaling inhibits human airway epithelial-mesenchymal transition and repair', International Journal of Biochemistry and Cell Biology, 68 59-69 (2015) [C1] 2015 Makkawi M, Moheimani F, Alserihi R, Howells D, Wright M, Ashman L, Jackson DE, 'A complementary role for tetraspanin superfamily member CD151 and ADP purinergic P2Y12 receptor in platelets.', Thromb Haemost, 114 1004-1019 (2015) [C1] 2014 Alshahrani MM, Yang E, Yip J, Ghanem SS, Abdallah SL, de Angelis AM, et al., 'CEACAM2 negatively regulates hemi (ITAM-bearing) GPVI and CLEC-2 pathways and thrombus growth in vitro and in vivo', BLOOD, 124 2431-2441 (2014) [C1] 2012 Moheimani F, Kim CHJ, Rahmanto AS, van Reyk DM, Davies MJ, 'Inhibition of lysosomal function in macrophages incubated with elevated glucose concentrations: A potential contributory factor in diabetes-associated atherosclerosis', ATHEROSCLEROSIS, 223 144-151 (2012) [C1] 2012 Moheimani F, Jackson DE, 'P2Y(12) receptor: platelet thrombus formation and medical interventions', INTERNATIONAL JOURNAL OF HEMATOLOGY, 96 572-587 (2012) [C3] 2011 Moheimani F, Tan JTM, Brown BE, Heather AK, van Reyk DM, Davies MJ, 'Effect of Exposure of Human Monocyte-Derived Macrophages to High, versus Normal, Glucose on Subsequent Lipid Accumulation from Glycated and Acetylated Low-Density Lipoproteins', EXPERIMENTAL DIABETES RESEARCH, (2011) [C1] 2011 Moheimani F, Jackson DE, 'Venous thromboembolism: classification, risk factors, diagnosis, and management.', ISRN hematology, 2011 124610 (2011) [C1] 2010 Moheimani F, Moore L, Ferrante JV, Trout N, Hii CS, Ferrante A, 'Inhibition of Atherosclerotic Lesion Development in the ApoE(-/-) Mouse by a Novel beta-oxa Polyunsaturated Fatty Acid', JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 56 431-439 (2010) [C1] 2010 Moheimani F, Morgan PE, van Reyk DM, Davies MJ, 'Deleterious effects of reactive aldehydes and glycated proteins on macrophage proteasomal function: Possible links between diabetes and atherosclerosis', BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 1802 561-571 (2010) [C1] 2003 Moheimani F, Bahri Najafi R, Mohammadi Samania S, Pishvab N, 'Formulation and Clinical Evaluation of Povidone-Iodine Ophthalmic Drop', Iranian Journal of Pharmaceutical Research, 2 157-160 (2003)